Results 171 to 180 of about 21,798 (199)

INTERFERON IN MYELOFIBROSIS

The Lancet, 1988
openaire   +2 more sources

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis

International Journal of Molecular Sciences, 2018
Byeong Bae Park, Moo-Kon Song, Song Moo-Kon   +2 more
exaly  

Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis

Future Oncology, 2015
Cecilia Arana Yi, Srdan Verstovšek, Constantine Tam   +2 more
exaly  

Primary Myelofibrosis

2008
openaire   +2 more sources

Idiopathic myelofibrosis: A clinical study of 80 patients

American Journal of Hematology, 1990
Hans Hasselbalch
exaly  

The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

Leukemia Research, 2009
Ruben Mesa, Claire Harrison, Animesh Pardanani   +2 more
exaly  

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients

Annals of Hematology, 2010
Eduardo Arellano-Rodrigo, Marina Díaz-Beyá   +1 more
exaly  

Polymorphonuclear Neutrophil and Megakaryocyte Mutual Involvement in Myelofibrosis Pathogenesis

Leukemia and Lymphoma, 2002
A Schmitt, Elisabeth M Cramer
exaly  

A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)

Leukemia Research, 2017
David Zhang, Vesna Najfeld, Min Lu
exaly  

Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

European Journal of Haematology, 2018
Lucia Masárová, Naveen Pemmaraju, Prithviraj Bose   +2 more
exaly